Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
Excutive Moves: CMC Biologics A/S

October 12, 2009
David Wolton has been named vice president manufacturing at CMC Biologics  Read More »
Onyx To Acquire Proteolix

October 12, 2009
Onyx Pharmaceuticals has signed an agreement to acquire Proteolix, Inc., a privately held biopharmaceutical company   Read More »
Hospira, Celltrion Enter Biogeneric Product Pact

October 9, 2009
Hospira has signed a business cooperation agreement with South Korea-based Celltrion for future distribution of biogeneric products in the U.S., Europe, Australia, New Zealand and Canada.  Read More »
Lycera Corp.

October 9, 2009
Paul S. Changelian, Ph.D. and Peter L. Toogood, Ph.D. have been appointed to Lycera Corp.'s drug development team.   Read More »
3M Drug Delivery Systems Adds Singapore Lab

October 8, 2009
3M Drug Delivery Systems is expanding its capabilities with a new lab site at its Singapore facility in Yishun.  Read More »
Creapharm Establishes U.S. Subsidiary

October 8, 2009
Creapharm Europe has established a U.S. subsidiary, Creapharm-MP5, Inc.   Read More »
NextPharma Expands Capabilities in U.S.

October 8, 2009
NextPharma has expanded its capabilities with the addition of clinical trial services at its San Diego, CA facility.   Read More »
Baxter Gets EU Approval for Celvapan H1N1

October 7, 2009
Baxter International, Inc. has been granted marketing authorization for Celvapan H1N1 pandemic vaccine from the European Commission.  Read More »
Catalent’s German Facility Successfully Audited

October 7, 2009
Catalent Pharma Solutions’ dose form development, manufacturing and packaging facility in Schorndorf, Germany, has successfully completed an FDA inspection.  Read More »
Charles River Shanghai Facility Gains Accreditations

October 7, 2009
Charles River Laboratories’ new Shanghai facility received accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), the Canadian Council on Animal Care (CCAC) and the Shanghai Laboratory Animal Commissi  Read More »
OctAlgos Therapeutics Inc.

October 6, 2009
Dr. Ganesh Iyer has been appointed president and chief executive officer, OctAlgos Therapeutics Inc., effective immediately.  Read More »
Onglyza Gains Approval in EU

October 6, 2009
Bristol-Myers Squibb and AstraZeneca were granted marketing authorization for Onglyza from the European Commission.  Read More »
OncoGenex Drug Gains Additional Fast Track Designation

October 6, 2009
OncoGenex Pharmaceuticals, Inc. received an additional Fast Track Designation from the FDA for OGX-011 (custirsen sodium) for progressive metastatic prostate cancer in combination with first-line docetaxel treatment.  Read More »
GSK, XenoPort Get Positive Pain Drug Results

October 5, 2009
GlaxoSmithKline and XenoPort, Inc. achieved positive results from a Phase II trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in patients with neuropathic pain associated with post-herpetic neuralgia (PHN), who have had an inadequate response to  Read More »
Pharmatek Acquires Xcelodose System

October 5, 2009
Pharmatek Laboratories, Inc. has acquired the Xcelodose 600S system, adding to its preclinical and early phase clinical GMP supply capabilities.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: